Corvus Pharmaceuticals (CRVS) Profit After Tax (QoQ) (2015 - 2025)
Corvus Pharmaceuticals (CRVS) Profit After Tax (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.17 Bn | 934.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -26.99% |
| Jun 30, 2025 | -152.53% |
| Sep 30, 2024 | -829.14% |
| Jun 30, 2024 | 25.24% |
| Mar 31, 2024 | 0.75% |
| Dec 31, 2023 | 4.27% |
| Sep 30, 2023 | 7.73% |
| Jun 30, 2023 | 17.40% |
| Mar 31, 2023 | -16.57% |
| Dec 31, 2022 | 54.46% |
| Sep 30, 2022 | -77.34% |
| Jun 30, 2022 | -0.80% |
| Mar 31, 2022 | 21.47% |
| Dec 31, 2021 | 1.11% |
| Sep 30, 2021 | 9.08% |
| Jun 30, 2021 | -1.49% |
| Mar 31, 2021 | -142.34% |
| Dec 31, 2020 | 379.16% |
| Sep 30, 2020 | 7.68% |
| Jun 30, 2020 | 17.97% |